AtriCure (ATRC) Total Current Liabilities (2010 - 2026)
AtriCure (ATRC) reported Total Current Liabilities of $73.2 million for Q1 2026, up 19.55% year-over-year from $61.2 million in Q1 2025, and down 10.22% quarter-over-quarter from $81.5 million in Q4 2025.
AtriCure (ATRC) Total Current Liabilities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Total Current Liabilities data on file, last reported at $73.2 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $73.2 million, up 19.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.2 million (up 19.55% YoY), and the FY2025 annual result was $81.5 million, up 11.03% from the prior year.
- Total Current Liabilities declined to $73.2 million in Q1 2026 per ATRC's latest filing, from $81.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $82.5 million in Q3 2023 and troughed at $47.4 million in Q1 2022.
- A 5-year average of $67.3 million and a median of $68.8 million in 2025 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities retreated 18.97% in 2022, then jumped 43.3% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $58.4 million in 2022, then advanced by 27.7% to $74.6 million in 2023, then retreated by 1.54% to $73.4 million in 2024, then rose by 11.03% to $81.5 million in 2025, then dropped by 10.22% to $73.2 million in 2026.
- Business Quant data shows ATRC's Total Current Liabilities at $73.2 million in Q1 2026, $81.5 million in Q4 2025, and $77.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn | 73.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.19 Mn |
| Dec 31, 2025 | 81.52 Mn |
| Sep 30, 2025 | 77.84 Mn |
| Jun 30, 2025 | 68.84 Mn |
| Mar 31, 2025 | 61.22 Mn |
| Dec 31, 2024 | 73.42 Mn |
| Sep 30, 2024 | 74.43 Mn |
| Jun 30, 2024 | 61.23 Mn |
| Mar 31, 2024 | 61.25 Mn |
| Dec 31, 2023 | 74.57 Mn |
| Sep 30, 2023 | 82.54 Mn |
| Jun 30, 2023 | 71.41 Mn |
| Mar 31, 2023 | 62.47 Mn |
| Dec 31, 2022 | 58.39 Mn |
| Sep 30, 2022 | 57.60 Mn |
| Jun 30, 2022 | 56.32 Mn |
| Mar 31, 2022 | 47.38 Mn |
| Dec 31, 2021 | 56.45 Mn |
| Sep 30, 2021 | 53.95 Mn |
| Jun 30, 2021 | 67.43 Mn |